| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,671 | 5,905 | 7,595 | 10,856 | | Cost of Revenue | 5,775 | 4,743 | 5,340 | 12,341 | | | Gross Profit | 1,896 | 1,162 | 2,255 | (1,486) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,073 | 4,328 | 5,716 | 7,548 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,177) | (3,165) | (3,461) | (9,034) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 758 | (1,537) | (1,542) | (143) | | Earnings Before Interest And Taxes | (2,418) | (4,702) | (5,003) | (9,177) | | Interest Expense | (14) | (16) | 77 |
-
| | Income Before Tax | (2,404) | (4,686) | (5,079) | (9,177) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,404) | (4,686) | (5,079) | (9,177) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,404) | (4,686) | (5,079) | (9,177) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,404) | ($4,686) | ($5,079) | ($9,177) |
|
0.40% Nasdaq 
Income Statement
